Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Minoo Battiwalla, MD, MS

State of the Science Summit - Hematologic Malignancies: Chaired by Minoo Battiwalla, MD, MS

State of the Science Summit - Hematologic Malignancies: Chaired by Minoo Battiwalla, MD,MS

Speakers

  • Clark Cutrer, MD | University of Tennessee Medical Center
  • Radhakrishnan Ramchandren, MD| University of Tennessee Medical Center
  • Stephen Strickland, MD | Sarah Cannon Transplant & Cellular Therapy Program at TriStar Centennial
  • Farrukh Awan, MD | UT Southwestern Medical Center
  • Jeremy Pantin, MD | Sarah Cannon Transplant & Cellular Therapy Program at TriStar Centennial

Topics

  • Navigating BTK Inhibitors in CLL
  • How Targeted Therapies Are Used in FL
  • Updates in Myeloid Malignancy
  • Bispecifics in DLBCL
  • Controversies in CAR T
  • Updates in Multiple Myeloma

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Ponatinib in patients with chronic-phase chronic myeloid leukemia and the T315I mutation: 4-year results from OPTIC
Sujith Samarasinghe, MD
Comparative Efficacy of Bruton Tyrosine Kinase Inhibitors in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia: A Network Meta-Analysis
Michael R. Grunwald, MD, FACP
Shella Saint Fleur-Lominy, MD, PhD
Manali Kamdar, MD
Matthew Matasar, MD, chief, Division of Blood Disorders, Rutgers Cancer Institute; professor, medicine, Rutgers Robert Wood Johnson Medical School
Sattva S. Neelapu, MD
Sattva S. Neelapu, MD
Julie M. Vose, MD, MBA